← feed

Is NCT03198676 results overdue?

Yes — results are overdue. Primary completion was 2017-05-24; the FDAAA-801 reporting deadline (2018-05-24) passed 2950 days ago and no results are posted on ClinicalTrials.gov.

A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production

NCT IDNCT03198676 ↗
SponsorPrep Biopharm Limited (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-05-24 (ACTUAL)
Reporting deadline2018-05-24 (completion + 365d)
Days overdue2950
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 88534b7e44e7b932… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03198676. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →